231 related articles for article (PubMed ID: 33461580)
1. Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma.
Dumond A; Brachet E; Durivault J; Vial V; Puszko AK; Lepelletier Y; Montemagno C; Pagnuzzi-Boncompagni M; Hermine O; Garbay C; Lagarde N; Montes M; Demange L; Grépin R; Pagès G
J Exp Clin Cancer Res; 2021 Jan; 40(1):33. PubMed ID: 33461580
[TBL] [Abstract][Full Text] [Related]
2. Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
Dumond A; Montemagno C; Vial V; Grépin R; Pagès G
Cells; 2021 May; 10(5):. PubMed ID: 34067671
[TBL] [Abstract][Full Text] [Related]
3. New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.
Zhao L; Chen H; Lu L; Wang L; Zhang X; Guo X
J Drug Target; 2021 Feb; 29(2):155-167. PubMed ID: 32838575
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis.
Yu DP; Zhou Y
Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects.
Borchardt H; Schulz A; Datta K; Muders MH; Aigner A
Sci Rep; 2019 Oct; 9(1):15471. PubMed ID: 31664117
[TBL] [Abstract][Full Text] [Related]
7. Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis.
Benwell CJ; Johnson RT; Taylor JAGE; Price CA; Robinson SD
Cancer Res Commun; 2022 Dec; 2(12):1626-1640. PubMed ID: 36970722
[TBL] [Abstract][Full Text] [Related]
8. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.
Schramek H; Sarközi R; Lauterberg C; Kronbichler A; Pirklbauer M; Albrecht R; Noppert SJ; Perco P; Rudnicki M; Strutz FM; Mayer G
Lab Invest; 2009 Nov; 89(11):1304-16. PubMed ID: 19736548
[TBL] [Abstract][Full Text] [Related]
10. CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway.
Zhang ZY; Xu JH; Zhang JL; Lin YX; Ou-Yang J
BMC Cancer; 2024 May; 24(1):650. PubMed ID: 38802739
[TBL] [Abstract][Full Text] [Related]
11. Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells.
DÍez GarcÍa de Olalla EV; Garofano F; Weiher H; Muders M; FÖrster S; Schmidt-Wolf IGH
Anticancer Res; 2020 Oct; 40(10):5489-5496. PubMed ID: 32988871
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity.
Sulpice E; Plouët J; Bergé M; Allanic D; Tobelem G; Merkulova-Rainon T
Blood; 2008 Feb; 111(4):2036-45. PubMed ID: 18065694
[TBL] [Abstract][Full Text] [Related]
13. NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model.
Liu WQ; Lepelletier Y; Montès M; Borriello L; Jarray R; Grépin R; Leforban B; Loukaci A; Benhida R; Hermine O; Dufour S; Pagès G; Garbay C; Raynaud F; Hadj-Slimane R; Demange L
Cancer Lett; 2018 Feb; 414():88-98. PubMed ID: 29111348
[TBL] [Abstract][Full Text] [Related]
14. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
15. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.
Boro A; Arlt MJ; Lengnick H; Robl B; Husmann M; Bertz J; Born W; Fuchs B
Am J Transl Res; 2015; 7(3):640-53. PubMed ID: 26045903
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a bead-based duplex assay for the simultaneous quantitative detection of Neuropilin-1 and Neuropilin-2 using xMAP technology and its clinical application.
Huang ZL; Meng PP; Yang Y; Wang SY; Zhang XF; Luo FH; Yan JH; Wu T
J Clin Lab Anal; 2019 May; 33(4):e22850. PubMed ID: 30758083
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
[TBL] [Abstract][Full Text] [Related]
19. Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.
Yoshida T; Ohe C; Ikeda J; Atsumi N; Saito R; Taniguchi H; Ohsugi H; Sugi M; Tsuta K; Matsuda T; Kinoshita H
J Pathol Clin Res; 2021 Nov; 7(6):590-603. PubMed ID: 34212534
[TBL] [Abstract][Full Text] [Related]
20. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
